Beta Bionics (BBNX) said Tuesday it has introduced Bionic Insights to help healthcare providers in interpreting diabetes patients' data.
The new feature supports healthcare providers to trace drivers behind glucose outcomes, lowering time spent evaluating raw data, and increasing time spent on "meaningful" patient care decisions, according to the company.